FeesSafety
Pluang+

Law firm probes HCA Healthcare over alleged securities fraud after profit guidance cut.

Market News
14 Oct 2026, 00:51 WIB
GlobeNewsWire
View Source
Bearish
Law firm probes HCA Healthcare over alleged securities fraud after profit guidance cut.

Pomerantz LLP is investigating HCA Healthcare and some of its executives for possible securities fraud following HCA's sharp reduction in its 2026 profit forecast due to a $400 million revenue hit from an unfavorable payer mix. This announcement caused HCA's stock to drop nearly 7% on July 14, 2026. The investigation could lead to a class action lawsuit if wrongdoing is found, highlighting risks investors face from sudden negative financial disclosures. Investors affected are encouraged to contact the law firm for potential claims.

HCA Healthcare's recent legal investigation news provides context for health sector trading on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 14, 2026 03:41 WIB: Among 128 priced US health-sector stocks, 29 rose and 99 fell today. Notable movers include NUWE (Nuwellis Inc) at USD 0.64 with a -5.27% change and a typical hold time of 27 days, TXG (10X Genomics Inc) at USD 71.79 down 4.52% with 92 days hold time, and ERAS (Erasca Inc.) at USD 14.78 down 4.40% with a 1-day hold time and 100% sell order activity.

More News

ArcaTrader launches 24/7 perpetuals trading for brokers and prop firms via Hyperliquid.

ArcaTrader launches 24/7 perpetuals trading for brokers and prop firms via Hyperliquid.

ArcaTrader has introduced 24/7 perpetuals trading powered by Hyperliquid on its multi-asset platform, allowing brokers and prop firms to offer continuous perpetuals alongside CFDs through one integrated system. This expansion enhances ArcaTrader's ex...

Others
Bullish
1 hour ago
Tempus AI reports 23% revenue growth and $193M from new data deals over 5 years

Tempus AI reports 23% revenue growth and $193M from new data deals over 5 years

Tempus AI reported a 23% year-over-year revenue increase to $411.5 million in Q3 2026, driven by rising test prices and multiyear biopharma licensing agreements expected to generate $193 million over five years. The company also anticipates an $80 mi...

Company Fundamentals
Bullish
1 hour ago
Planet Labs secures new rocket launches from Stoke Space as SpaceX plans to retire Falcon 9 by 2028

Planet Labs secures new rocket launches from Stoke Space as SpaceX plans to retire Falcon 9 by 2028

Planet Labs, which operates the largest Earth observation satellite fleet, faces a challenge as SpaceX plans to retire its Falcon 9 rockets by 2028. To maintain its satellite launches, Planet Labs has signed a multi-launch agreement with Stoke Space ...

Market News
Bullish
1 hour ago
Sigma Lithium cuts short-term debt 85%, targets 330,000 tons lithium production in 2027 with low costs.

Sigma Lithium cuts short-term debt 85%, targets 330,000 tons lithium production in 2027 with low costs.

Sigma Lithium reduced its short-term debt by 85% through a $125 million convertible note refinancing, easing financial pressure for expansion. The company reported low all-in sustaining costs of $642 per ton, well below the average lithium price of $...

Company Fundamentals
Bullish
1 hour ago
Novartis forecasts 5% sales growth CAGR through 2031 with upgraded peak sales for key drugs.

Novartis forecasts 5% sales growth CAGR through 2031 with upgraded peak sales for key drugs.

Novartis projects a 5% compound annual growth rate (CAGR) in net sales from 2026 to 2031 and aims to restore its core operating income margin to over 40% by 2029. The company raised peak sales forecasts for key drugs Kesimpta, Scemblix, and Leqvio, r...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App